Product Information
Name:IBL-302
Synonyms:
- AMU302
Brand:Targetmol
Description:IBL-302 (AMU302), an orally available dual-signaling inhibitor targeting PIM and PI3K/AKT/mTOR, is effective against breast cancer and neuroblastoma. It has shown in vivo efficacy in a nude mouse xenograft model by combating trastuzumab resistance. Additionally, IBL-302 augments the effectiveness of widely used cytotoxic chemotherapy drugs such as cisplatin, doxorubicin, and etoposide [1] [2] [3].
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:567.64
Formula:C25H18FN5O4S3
Color/Form:Solid
Technical inquiry about: IBL-302
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.